Prokidney (PROK) Cash from Financing Activities (2021 - 2026)

Prokidney (PROK) has reported Cash from Financing Activities for 6 consecutive years, with $541000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Financing Activities rose 3964.29% year-over-year to $541000.0 in Q2 2026; TTM through Jun 2026 was $26.4 million, a 478.76% increase from a year earlier, with the FY2025 full-year figure at $25.6 million, down 82.29% from the prior year.
• Cash from Financing Activities was $541000.0 for Q2 2026 at Prokidney, up from $215000.0 in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $507.5 million in Q3 2022 and troughed at -$9.5 million in Q4 2023.
• A 5-year average of $39.4 million and a median of $169000.0 in 2024 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities surged 18508595.65% in 2022 and sank 118800.0% in 2023, its largest moves.
• Over 5 years, Cash from Financing Activities stood at -$8000.0 in 2022, then slumped by 118800.0% to -$9.5 million in 2023, then jumped by 101.29% to $123000.0 in 2024, then soared by 14236.59% to $17.6 million in 2025, then slumped by 96.93% to $541000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $541000.0 (Q2 2026), $215000.0 (Q1 2026), and $17.6 million (Q4 2025), per Business Quant data.